Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cytokinetics Inc (CYTK) vs Viasat (VSAT) Price & Performance

Cytokinetics IncTrade

Price performance (Past 24H)

Key statistics

Cytokinetics Inc vs Viasat — how do they compare? Cytokinetics Inc trades at $61.95 (market cap $8.62B), while Viasat trades at $69.98 (market cap $9.29B). The key difference: Cytokinetics Inc and Viasat are close in size by market cap, and Viasat is trading nearer its 52-week high, Cytokinetics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cytokinetics Inc for 19 Days and Viasat for 10 Days on average.

CYTKVSAT
Market Cap
$8.62B$9.29B
Volume
2,594,6262,084,105
Sector
HealthTechnology
52-Week High
$87.26$89.81
52-Week Low
$54.76$30.35
Typical Hold Time
19 Days10 Days
Enterprise Value
$8.72B$14.48B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cytokinetics Inc

Cytokinetics (CYTK) trades at $61.12, down 0.37% on the day, with a bearish technical signal from moving averages despite some oversold RSI readings. The company reported a net loss of $784.96 million on $88.04 million revenue in 2025, with a negative net income margin of -1,321.12% in 2026. Recent news highlights clinical progress for aficamten in hypertrophic cardiomyopathy and executive stock sales.

Wall Street maintains strong bullish sentiment with a 97.14% buy rating and $112.60 consensus price target, but high cash burn, persistent losses, and insider selling pose significant risks. The stock's outlook hinges on successful commercialization of its heart failure pipeline amid substantial financial and competitive pressures.

Viasat

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CYTK
100% Buy0% Sell
Avg holding period · 19 Days
VSAT

No sentiment data available yet.

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.

Read more on CYTK →

About Viasat

Viasat provides satellite communications and connectivity services for aviation, maritime, government, enterprise, and consumer markets. Its network combines satellite and ground infrastructure to deliver connectivity in remote and mobile environments.

Read more on VSAT →